Stay updated on Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.

Latest updates to the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page
- Check5 days agoChange DetectedThe study record for this phase 2 trial is displayed with its eligibility criteria, treatment cohorts, outcomes, locations, and study history. It also indicates that the study is completed and no longer recruiting participants.SummaryDifference70%

- Check12 days agoChange DetectedThe site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the study record content and navigation. This change blocks access to the trial details and related information on the site.SummaryDifference21%

Stay in the know with updates to Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.